Jocelyne Guay

4.9k total citations
42 papers, 2.5k citations indexed

About

Jocelyne Guay is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Jocelyne Guay has authored 42 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Pharmacology and 13 papers in Organic Chemistry. Recurrent topics in Jocelyne Guay's work include Inflammatory mediators and NSAID effects (15 papers), Estrogen and related hormone effects (8 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Jocelyne Guay is often cited by papers focused on Inflammatory mediators and NSAID effects (15 papers), Estrogen and related hormone effects (8 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Jocelyne Guay collaborates with scholars based in Canada, United States and United Kingdom. Jocelyne Guay's co-authors include Denis Riendeau, Joseph A. Mancini, Robert J. Gordon, Chi‐Chung Chan, Jean‐Pierre Falgueyret, David Claveau, S. Charleson, Elizabeth Wong, Diane Ethier and Wanda Cromlish and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Jocelyne Guay

40 papers receiving 2.4k citations

Peers

Jocelyne Guay
Chi‐Chung Chan Canada
Christine Brideau Canada
Aaron B. Miller United States
Marc Ouellet Canada
C S Ramesha United States
Danielle Denis Canada
Brad R. Henke United States
Xin Hua Liu China
Claude Dufresne United States
Jih-Pyang Wang Taiwan
Chi‐Chung Chan Canada
Jocelyne Guay
Citations per year, relative to Jocelyne Guay Jocelyne Guay (= 1×) peers Chi‐Chung Chan

Countries citing papers authored by Jocelyne Guay

Since Specialization
Citations

This map shows the geographic impact of Jocelyne Guay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jocelyne Guay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jocelyne Guay more than expected).

Fields of papers citing papers by Jocelyne Guay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jocelyne Guay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jocelyne Guay. The network helps show where Jocelyne Guay may publish in the future.

Co-authorship network of co-authors of Jocelyne Guay

This figure shows the co-authorship network connecting the top 25 collaborators of Jocelyne Guay. A scholar is included among the top collaborators of Jocelyne Guay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jocelyne Guay. Jocelyne Guay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boulet, Louise, Christine Brideau, David Claveau, et al.. (2011). Trisubstituted ureas as potent and selective mPGES-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(5). 1488–1492. 22 indexed citations
2.
Powell, David, W. Cameron Black, Kelly Bleasby, et al.. (2011). Nicotinic acids: Liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy. Bioorganic & Medicinal Chemistry Letters. 21(24). 7281–7286. 15 indexed citations
3.
Ramtohul, Yeeman K., David Powell, Jean‐Philippe Leclerc, et al.. (2011). Bicyclic heteroaryl inhibitors of stearoyl-CoA desaturase: From systemic to liver-targeting inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(19). 5692–5696. 16 indexed citations
4.
Isabel, Élise, David Powell, W. Cameron Black, et al.. (2010). Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(1). 479–483. 24 indexed citations
5.
Li, Chun Sing, et al.. (2009). Thiazole analog as stearoyl-CoA desaturase 1 inhibitor. Bioorganic & Medicinal Chemistry Letters. 19(17). 5214–5217. 38 indexed citations
6.
Côté, Bernard, Louise Boulet, Christine Brideau, et al.. (2007). Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(24). 6816–6820. 116 indexed citations
7.
Clark, Patsy, Robert J. Gordon, Jocelyne Guay, et al.. (2007). Pharmacological characterization of a selective COX-2 inhibitor MF-tricyclic, [3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone], in multiple preclinical species. European Journal of Pharmacology. 560(2-3). 216–224. 12 indexed citations
8.
Grimm, Erich L., Christine Brideau, Nathalie Chauret, et al.. (2006). Substituted coumarins as potent 5-lipoxygenase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(9). 2528–2531. 44 indexed citations
9.
Massé, Frédéric, Sébastien Guiral, Elizabeth Cauchon, et al.. (2005). An Automated Multistep High-Throughput Screening Assay for the Identification of Lead Inhibitors of the Inducible Enzyme mPGES-1. SLAS DISCOVERY. 10(6). 599–605. 14 indexed citations
10.
Guay, Jocelyne, Kevin P. Bateman, Robert J. Gordon, Joseph A. Mancini, & Denis Riendeau. (2004). Carrageenan-induced Paw Edema in Rat Elicits a Predominant Prostaglandin E2 (PGE2) Response in the Central Nervous System Associated with the Induction of Microsomal PGE2 Synthase-1. Journal of Biological Chemistry. 279(23). 24866–24872. 230 indexed citations
11.
12.
Lau, Cheuk K., Christine Brideau, Chi Chung Chan, et al.. (1999). Synthesis and biological evaluation of 3-heteroaryloxy-4-phenyl-2(5H)-furanones as selective COX-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(22). 3187–3192. 25 indexed citations
13.
Frenette, Richard, John H. Hutchinson, Serge Léger, et al.. (1999). Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(16). 2391–2396. 11 indexed citations
14.
Black, W. Cameron, Christine Brideau, S. Charleson, et al.. (1999). A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(22). 3181–3186. 23 indexed citations
15.
LEBLANC, Y., Patrick Roy, S. Boyce, et al.. (1999). SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor. Bioorganic & Medicinal Chemistry Letters. 9(15). 2207–2212. 38 indexed citations
16.
Guay, Jocelyne, Denis Riendeau, & Joseph A. Mancini. (1999). Cloning and expression of rhesus monkey cathepsin K. Bone. 25(2). 205–209. 12 indexed citations
17.
Dubé, Daniel, Marc Blouin, Christine Brideau, et al.. (1998). Quinolines as potent 5-lipoxygenase inhibitors: Synthesis and biological profile of L-746,530. Bioorganic & Medicinal Chemistry Letters. 8(10). 1255–1260. 244 indexed citations
18.
Ducharme, Yves, Christine Brideau, Daniel Dubé, et al.. (1994). Naphthalenic Lignan Lactones as Selective, Nonredox 5-Lipoxygenase Inhibitors. Synthesis and Biological Activity of (Methoxyalkyl)thiazole and Methoxytetrahydropyran Hybrids. Journal of Medicinal Chemistry. 37(4). 512–518. 31 indexed citations
19.
20.
Riendeau, Denis, et al.. (1991). Inhibition of leukotriene B4 biosynthesis by disulfiram and A-64077 during carrageenan-induced pleurisy in the rat. General Pharmacology The Vascular System. 22(2). 371–374. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chi‐Chung Chan Breakdown of academic impact, for papers by Christine Brideau Breakdown of academic impact, for papers by Aaron B. Miller Breakdown of academic impact, for papers by Marc Ouellet Breakdown of academic impact, for papers by C S Ramesha Breakdown of academic impact, for papers by Danielle Denis Breakdown of academic impact, for papers by Brad R. Henke Breakdown of academic impact, for papers by Xin Hua Liu Breakdown of academic impact, for papers by Claude Dufresne Breakdown of academic impact, for papers by Jih-Pyang Wang
Rankless by CCL
2026